Induced amplification method of CIK2 (NK NK-T) cells
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- 上海映天生物科技有限公司
- Publication Date
- 2021-02-12
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of biotechnology, in particular to a method for inducing and expanding CIK2 (NK NK-T) cells. Background technique
[0002] "Cytokine-induced killer cells" (CIK) are lymphocytes isolated from human peripheral blood that are induced and activated by CD3 monoclonal antibody, γ-interferon, interleukin-1, interleukin-2 and other cytokines, and have the ability to recognize and kill tumor cells, Inhibit the virus and regulate the body's immunity and can cultivate a large number of expanded immune cells. This activated immune cell has a strong proliferation ability, mainly composed of NK-like T cells (CD56 + CD3 + ), T(CD3 + CD8 + ) dominated cell population. It has the advantages of anti-tumor activity of T lymphocytes and non-MHC-limited tumor killing of NK cells. The cells can recognize and kill a variety of tumor cells without harming normal cells in the body. The effect of infusion after surgery or radiotherapy and...